drugset
drugset / Trial / NCT00652665

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

NCT00652665 ↗

Phase 1 Completed 52 enrolled Par Pharmaceutical, Inc. Novum Pharmaceutical Research Services · collab
RandomizedCrossoverOpen-label

Summary

To compare the single-dose Bioavailability of Kali and Aventis

Timeline

Start
2003-06
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Leflunomide Small molecule 20 mg —

Indications

No indication recorded.